Efficacy and safety of nanoparticle albumin-bound paclitaxel monotherapy as second-line therapy of cytotoxic anticancer drugs in patients with advanced non-small cell lung cancer.
about
Efficacy and safety of nanoparticle albumin-bound paclitaxel monotherapy as second-line therapy of cytotoxic anticancer drugs in patients with advanced non-small cell lung cancer.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Efficacy and safety of nanopar ...... ed non-small cell lung cancer.
@en
Efficacy and safety of nanopar ...... ed non-small cell lung cancer.
@nl
type
label
Efficacy and safety of nanopar ...... ed non-small cell lung cancer.
@en
Efficacy and safety of nanopar ...... ed non-small cell lung cancer.
@nl
prefLabel
Efficacy and safety of nanopar ...... ed non-small cell lung cancer.
@en
Efficacy and safety of nanopar ...... ed non-small cell lung cancer.
@nl
P2093
P2860
P1433
P1476
Efficacy and safety of nanopar ...... ced non-small cell lung cancer
@en
P2093
Kiyoshi Kanno
Kohei Shiozaki
Makiko Yamaguchi
Masaki Anzai
Masaya Akai
Miwa Morikawa
Shingo Ameshima
Takehiro Okuno
Tamotsu Ishizuka
Tomoaki Sonoda
P2860
P356
10.1097/MD.0000000000009320
P407
P577
2017-12-01T00:00:00Z